AngioWaveNet vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Angiowave Imaging
VS
by RhythmScience

AI Verdict

AngioWaveNet is an AI tool focused on enhancing fluoroscopic angiograms for improved vessel visualization during cardiac catheterization procedures. Rhythm360, conversely, is an AI-powered platform that aggregates and analyzes cardiac monitoring data to manage conditions like hypertension and heart failure, and reduce alert fatigue. While both operate in cardiology, AngioWaveNet targets interventional imaging, and Rhythm360 focuses on data management and remote patient monitoring.

Choose AngioWaveNet if…

Choose AngioWaveNet if your primary goal is to enhance the clarity and detail of fluoroscopic angiograms during cardiac catheterization procedures. This tool is ideal for cath labs seeking to improve real-time vessel visualization and anatomical feature identification, integrating seamlessly with existing angiography systems regardless of vendor.

View AngioWaveNet →

Choose Rhythm360 if…

Choose Rhythm360 if your practice requires a comprehensive platform for aggregating and analyzing cardiac monitoring data from diverse remote devices. This solution is best suited for managing chronic conditions like hypertension, heart failure, and arrhythmias, leveraging AI to reduce alert fatigue and streamline patient management workflows, including automated billing and EHR integration.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet Rhythm360
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Flexible pricing model that scales with clinic size and platform usage.
Deployment Cloud-based or on-premise/servers Cloud-based SaaS platform
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

While AngioWaveNet integrates seamlessly into existing Cath lab workflows and is vendor-agnostic, Rhythm360 offers broader usability. Its extensive bi-directional EHR integration with major systems, vendor-neutral data aggregation from various devices, and a HIPAA-compliant mobile application provide wider accessibility and integration across diverse clinical settings for clinicians.

Clinical Value

AngioWaveNet

AngioWaveNet is FDA-cleared and directly enhances fluoroscopic angiograms for improved vessel visualization, which is critical for diagnostic accuracy and procedural guidance in cardiac catheterization. Rhythm360 offers significant value in chronic disease management and workflow efficiency, but AngioWaveNet's direct impact on improving real-time diagnostic quality during a critical procedure is a fundamental and validated clinical improvement.

Pricing & Value

AngioWaveNet

Both tools offer flexible and scalable pricing models. However, Rhythm360 is explicitly described as having 'premium pricing' as a potential con. AngioWaveNet's pricing options, tailored to cath lab volume and hospital needs without the 'premium' label, suggest potentially better value or at least more transparently flexible options.

Enterprise Readiness

Rhythm360

AngioWaveNet offers strong compliance and flexible deployment options. However, Rhythm360 demonstrates superior enterprise readiness through its comprehensive bi-directional EHR integration with multiple major systems, vendor-neutral data aggregation from all major OEM devices, and particularly its automated CPT code documentation and billing features, which streamline administrative workflows crucial for large-scale adoption.

Innovation

Rhythm360

AngioWaveNet innovates by applying AI for spatiotemporal enhancement of angiographic images. Rhythm360, however, showcases broader and more diverse AI innovation, encompassing vendor-neutral data aggregation, predictive algorithms for heart failure management, AI-driven alert triage, and advanced AI Data Normalization including PDF parsing via computer vision, demonstrating a wider scope of AI application in cardiac care.

Support & Docs

Rhythm360

The provided information does not detail standard support or documentation for AngioWaveNet. Rhythm360, conversely, explicitly offers optional 24/7/365 oversight by certified cardiac technicians. This level of dedicated, continuous operational support, even if optional, suggests a more comprehensive and robust support ecosystem for Rhythm360 users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet Rhythm360
Name AngioWaveNet Rhythm360
Company Angiowave Imaging RhythmScience
Primary Use Case Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Core AI Functionality AI-powered Spatiotemporal Enhancement Processing (STEPu2122); Post-processing AI for angiographic images. AI-driven alert triage; AI Data Normalization; Predictive algorithms for Heart Failure Management.
Vendor Agnostic/Neutrality Compatible with any fluoroscopic angiography system (vendor-agnostic) Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik)
Integration Capabilities Integrates with existing Cath lab workflows; Functions as a DICOM endpoint for imaging systems. Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity); API, HL7, XML, PDF parsing.

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet is FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. Rhythm360 is an AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
AngioWaveNet integrates with existing Cath lab workflows and is compatible with any fluoroscopic angiography system, functioning as a DICOM endpoint. Rhythm360 offers vendor-neutral data aggregation from all major cardiac device OEMs and bi-directional EHR integration with systems like Epic, Cerner, Athenahealth, eClinicalWorks, and GreenwayHealth.
AngioWaveNet processes angiographic images from fluoroscopic angiography systems. Rhythm360 unifies cardiac monitoring data from various devices and integrates with EHRs, utilizing APIs, HL7, XML, and PDF parsing via computer vision for data normalization.
AngioWaveNet focuses on clinical image enhancement and does not specify administrative or billing features. Rhythm360 includes automated CPT code documentation and billing for codes such as 93298, 93299, 99454, 99453, and 99457, aiming to boost practice revenue and reduce administrative burden.
AngioWaveNet aims to improve vessel visualization in fluoroscopic angiograms, which can be challenging for diagnosing coronary artery disease. Rhythm360 aims to provide actionable insights for hypertension, heart failure, and rhythm management, and to reduce alert fatigue by triaging alerts based on importance.
AngioWaveNet is FDA-cleared AI software and is HIPAA compliant, operating within secure hospital networks. Rhythm360 is HIPAA compliant, has a Business Associate Agreement (BAA), and is SOC 2 certified.
AI Tool Finder
AI-powered search. Results may not be comprehensive.